The Impact Of PEGs In The Small Molecule API Market

Polyethylene Glycol (PEG) plays a pivotal role in modern drug development, influencing everything from formulation stability to therapeutic performance. Choosing between off-the-shelf and custom activated PEGs can significantly impact timelines, costs, and regulatory compliance. A deep understanding of regulatory requirements is critical across all phases, from early development through clinical trials and commercial launch. This webinar examines the complexities of PEG development and manufacturing, offering strategies to optimize efficiency and mitigate risk. Learn why partnering with an experienced CDMO can streamline your program and deliver tailored PEG solutions that meet your unique specifications, as well as gain actionable insights to strengthen your small molecule drug pipeline and accelerate success.

Watch now to uncover best practices for PEG integration and CDMO selection.